Athanasios D. Anastasilakis
Ring Road
Thessaloniki, ESYE12 56429, Greece
Thessaloniki, ESYE12 56429, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 186 publications
Response to Letter to the Editor on "Romosozumab for the treatment of thalassemia-associated osteoporosis in two female patients".
Journal: JBMR plus
Published: June 16, 2026
Vitamin D Levels and Skeletal Quality of Life in Adult Langerhans Cell Histiocytosis.
Journal: Endocrine connections
Published: May 27, 2026
Challenges in Sequential Antiresorptive Therapy After Long-Term Denosumab Discontinuation: A Case Report and Narrative Review of the Literature.
Journal: Journal of clinical medicine
Published: May 24, 2026
Effectiveness of Anti-Osteoporotic Medications in the Management of Glucocorticoid-Induced Osteoporosis: A Systematic Review and Network Meta-Analysis on Behalf of the ECTS Clinical Action Group.
Journal: European journal of endocrinology
Published: April 13, 2026
Pathophysiology, diagnosis and management of secondary osteoporosis.
Journal: Nature reviews. Endocrinology
Published: March 27, 2026
Exploring the relationship between microplastic exposure and bone health.
Journal: Endocrine connections
Published: March 10, 2026
Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: February 21, 2026
Alendronate for 6 or 12 months following denosumab discontinuation in women with postmenopausal osteoporosis: A prospective observational study.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: February 10, 2026
Magnesium as an endocrine modulator: physiological roles, clinical evidence, and therapeutic perspectives.
Journal: European journal of endocrinology
Published: February 09, 2026
Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice.
Journal: Frontiers in endocrinology
Published: January 08, 2026
Bone Adverse Events in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Comprehensive Review of the Literature from the Clinical Action Group of the European Calcified Tissue Society.
Journal: Calcified tissue international
Published: November 09, 2025
Last Updated: 09/26/2026